A61K 39/104
Pseudomonadales
Official title: {Pseudomonadales, e.g.} Pseudomonas
A61K39/104 (Pseudomonadales) appears on 187 US grants and 280 published applications in this corpus.
Search patents in A61K- Granted patents
- 187
- Published applications
- 280
- Assignees
- 180
- Inventors
- 546
- Latest grant
- 23 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 3 | 0 |
| 1979 | 2 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 3 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 4 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 3 |
| 2003 | 1 | 4 |
| 2004 | 3 | 6 |
| 2005 | 5 | 7 |
| 2006 | 1 | 9 |
| 2007 | 1 | 5 |
| 2008 | 2 | 8 |
| 2009 | 5 | 8 |
| 2010 | 6 | 14 |
| 2011 | 4 | 7 |
| 2012 | 4 | 14 |
| 2013 | 6 | 8 |
| 2014 | 9 | 8 |
| 2015 | 4 | 15 |
| 2016 | 8 | 17 |
| 2017 | 8 | 18 |
| 2018 | 17 | 18 |
| 2019 | 10 | 11 |
| 2020 | 14 | 21 |
| 2021 | 15 | 10 |
| 2022 | 8 | 20 |
| 2023 | 7 | 13 |
| 2024 | 7 | 16 |
| 2025 | 8 | 13 |
| 2026 | 6 | 7 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Monoclonal antibody and vaccine targeting filamentous bacteriophage23 Jun 2026US 12,661,411 B2Inimmune Corporation
- Bacterial membrane vesicles, and separation and preparation system and method therefor9 Jun 2026US 12,648,990 B2Sichuan University
- Vaccines targeting Pseudomonas aeruginosa21 Apr 2026US 12,606,597 B2Evaxion Biotech A/S
- Method for the production of outer membrane vesicles and immunogenic compositions thereof17 Feb 2026US 12,551,544 B2Biomvis Srl
- Methods for preparing aluminum precipitate compounds for use in therapeutics and vaccines20 Jan 2026US 12,527,863 B2Valneva Austria GmbH
- Inhaled adenovirus vector vaccine, preparation method therefor and use thereof8 Oct 2026US 2026/0306605 A1Cansino Biologics Inc.
- A broadly protective prophylactic vaccine against pseudomonas aeruginosa24 Sep 2026US 2026/0284172 A1University of Kansas
- Vaccines targeting pseudomonas aeruginosa10 Sep 2026US 2026/0265312 A1Evaxion Biotech A/S
- Methods for preparing aluminum precipitate compounds for use in therapeutics and vaccines16 Jul 2026US 2026/0199456 A1Valneva Austria GmbH
- Acinetobacter vaccine and method of use thereof9 Jul 2026US 2026/0191944 A1Washington University
Most cited
By later US patents
- Polyvalent shipping fever vaccine42US 4,167,560 ATexas Vet Lab, Inc. · 1979
- Vaccines for gram-negative bacteria42US 4,663,160 AMiles Laboratories, Inc. · 1987
- Method for producing a vaccine against bacterial infections caused by pseudomonas aeruginosa39US 4,285,936 AThe United States of America as represented by the Secretary of the Army · 1981
- Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa36US 4,578,458 AThe Brigham and Women S Hospital, Inc. · 1986
- Prevention and treatment of rheumatoid arthritis36US 4,732,757 AStolle Research & Development Corporation · 1988